期刊文献+

炎症与无症状性心肌缺血的研究进展 被引量:2

下载PDF
导出
摘要 动脉粥样硬化是一种炎症性疾病,在无症状心肌缺血中,炎症因子的表达有何特点及机制,本文就此对国内、外研究进展作一综述。
出处 《心血管康复医学杂志》 CAS 2010年第3期328-331,共4页 Chinese Journal of Cardiovascular Rehabilitation Medicine
  • 相关文献

参考文献4

二级参考文献29

  • 1Ye S. Influence of matrix metalloproteinase genotype cardiovascular disease susceptibility and outcome. Cardiovasc Res, 2006,69:636-645.
  • 2Zhou X, Huang J, Chen J,et al. Haplotype analysis of the matrix metalloproteinase 3 gene and myocardial infarction in a Chineses Han population. The Beijing atherosclerosis study. Thromb Haemost, 2004,92 : 867-873.
  • 3Ye S, Watts GF, Mandalia S, et al. Preliminary report: genetic variation in the human stromelysin promoter is associated with progression of coronary atherosclerosis. Br Heart J, 1995,73:209- 215.
  • 4Ye S, Eriksson P, Hamsten A, et al. Progression of coronary atherosclerosis is associated with a common genetic variant of the human stromelysin-1 promoter which results in reduced gene expression. J Biol Chem, 1996,271:13055-13060.
  • 5Beyzade S, Zhang S, Wong YK, et al. Influences of matrix metalloproteinase-3 gene variation on extent of coronary atherosclerosis and risk of myocardial infarction. J Am Coil Cardiol,2003,41:2130-2137.
  • 6Medley TL, Kingwell BA, Gatzka CD, et al. Matrix metalloproteinase-3 genotype contributes to age-related aortic stiffening through modulation of gene and protein expression. Circ Res, 2003,92:1254-1261.
  • 7Lichtinghagen R, Bahr MJ, Whemeier M, et al. Expression and coordinated regulation of matrix metalloproteinases in chronic hepatitis C and hepatitis C virus-induced liver cirrhosis. Clin Sci (Lond) ,2003,105:373-382.
  • 8Silence J, Lupu F, Collen D, et al. Persistence of atherasclerotic plaque but reduced aneurysm formation in mice with stromelysin-1 (bibiP-3) gene inactivation. Arterioscler Thromb Vase Biol, 2001,21 : 1440-1445.
  • 9Humphries SE, Luong LA, Talmud PJ, et al. The 5A/6A polymorphism in the promoter of the stromelysin-1 ( MMP-3 ) gene predicts progression of angiographically determined coronary artery disease in men in the LOCAT gemfibrozil study. Lopid Coronary Angiongraphy Trial. Atherosclerosis, 1998,139:49-56.
  • 10de Maat MP, Jukema JW, Zwinderman AH, et al. Effect of the stromelysin-1 promoter on efficacy of pravastatin in coronary atherosclerosis and restenosis. Am J Cardiol, 1999,83:852-856.

共引文献179

同被引文献35

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部